Reuters logo
7 months ago
BRIEF-Portola Pharmaceuticals Inc signed a $150 million royalty agreement with Healthcare Royalty Partners
February 3, 2017 / 1:21 PM / 7 months ago

BRIEF-Portola Pharmaceuticals Inc signed a $150 million royalty agreement with Healthcare Royalty Partners

Feb 3 (Reuters) - Portola Pharmaceuticals Inc :

* Portola Pharmaceuticals Inc - signed a $150 million royalty agreement with healthcare royalty partners

* Portola Pharma - received $50 million at closing and may receive additional $100 million upon FDA approval of andexxa for a tiered, mid-single-digit royalty

* Portola Pharmaceuticals Inc - agreement is subject to a maximum total royalty payment of 195 percent of $150 million funded by HCR

* Portola - received CRL from FDA regarding biologics license application for andexanet alfa in aug 2016; expects to resubmit application in H1 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below